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Natural products have attracted interest in the search for new and effective analgesics
and coadjuvant approaches to several types of pain. It is in fact well known that
many of their active ingredients, such as anthocyanins (ACNs) and polyphenols, can
exert potent anti-inflammatory actions. Nevertheless, their potential beneficial effects
in orofacial painful syndromes have not been assessed yet. Here, we have evaluated
the preventive effect of an ACN-enriched purple corn extract against the development
of orofacial allodynia, in comparison with isogenic yellow corn extract containing only
polyphenols. Orofacial allodynia developed following induction of temporomandibular
joint (TMJ) inflammation in male rats, due to the injection of Complete Freund’s Adjuvant
(CFA), and was evaluated by von Frey filaments. Animals drank purple or yellow corn
extracts or water starting from 11 days before induction of inflammation and up to
the end of the experiment 3 days later. To highlight possible additive and/or synergic
actions, some animals also received the anti-inflammatory drug acetyl salicylic acid
(ASA). In parallel with the evaluation of allodynia, we have focused our attention on the
activation of microglia cells in the central nervous system (CNS), as it is well-known that
they significantly contribute to neuronal sensitization and pain. Our data demonstrate
that purple corn extract is as effective as ASA in preventing the development of
orofacial allodynia, and only partial additive effect is observed when the two agents
are co-administered. Yellow corn exerted no effect. Multiple mechanisms are possibly
involved in the action of purple corn, including reduction of trigeminal macrophage
infiltration and the shift of microglia cell polarization to an anti-inflammatory phenotype. In
fact, in rats receiving yellow corn or water microglia cells show thick, short cell processes
typical of activated cells. Conversely, thinner and longer microglia cell processes are
observed in the brainstem of animals drinking purple corn extract; shape changes
are accompanied by a reduction in the expression of pro-inflammatory molecules and
increased production of anti-inflammatory mediators. Administration of purple corn
extracts therefore represents a possible low-cost and easy way to reduce trigeminal-
associated pain in various pathological conditions also thanks to the modulation of
microglia reactivity.
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INTRODUCTION
Alternative and complementary approaches to currently
available painkillers are now attracting researchers and
clinicians, with the dual aim of reducing drug-associated
side effects and to possibly find more effective treatments
for conditions lacking satisfactory management protocols.
This is the case of various types of trigeminal-related pain,
including temporomandibular joint (TMJ) pain which
arises from a heterogeneous group of musculoskeletal and
neuromuscular problems (Gauer and Semidey, 2015). TMJ pain
is characterized by a strong inflammatory component, and the
first line pharmacological treatment is currently represented
by non-steroidal anti-inflammatory drugs (NSAIDs), which
sometimes lead to only partial pain relief accompanied by the
risk of the well-known and potentially life-threatening side
effects (i.e., bleeding, gastrointestinal ulcerations, drug/drug
interactions in the case of multitherapy, allergic reactions in a
percentage of subjects). Benzodiazepines and capsaicin are also
utilized (Häggman-Henrikson et al., 2017).
The lack of effective therapies is also based on the common
idea that analgesics should target neurons. In recent years,
research has instead demonstrated a significant contribution
to pain of non-neuronal cells, both in the central nervous
system (CNS) and in periphery.We demonstrated that brainstem
microglial cells and trigeminal ganglion glial cells are activated
by the induction of TMJ pain in adult male rats (Villa et al.,
2010; Magni et al., 2015), thus contributing to the development
of a pro-inflammatory milieu which in turn is responsible for the
development of neuronal sensitization and the chronicization of
pain.
Naturally-occurring anti-inflammatory molecules, such as
anthocyanins (ACNs) and polyphenols which can be easily
administered to patients as extracts or functional foods, have
attracted the interest of the scientific community as adjuvants
and complements to drug therapy. In particular, evidence that
consumption of ACN-rich food promotes health is supported
by epidemiological and preclinical studies performed with
different dietary sources of ACNs, showing that they can
protect against cancer, cardiovascular disease and age-related
neurodegenerative diseases, all characterized by the development
of inflammation (Joseph et al., 1999; Butelli et al., 2008;
Toufektsian et al., 2008; He and Giusti, 2010; Tsuda, 2012;
Cassidy et al., 2013; Jennings et al., 2014). Furthermore, dietary
ACNs from purple corn have been shown to protect against
myocardial damages induced by Doxorubicin, an anthracycline
widely used as chemotherapeutic drug against a variety of
cancer types (Petroni et al., 2017). Interestingly, purple corn
extract does not affect the cytotoxic effects of Doxorubicin on
tumor cells, suggesting it as a beneficial functional food for
patients subjected to anthracycline chemotherapy (Petroni et al.,
2017).
Based on these premises, we have deemed it interesting to
evaluate the possible anti-allodynic action of the administration
of a purple corn extract (Red extract) to rats exposed to
inflammatory TMJ pain, in parallel with isogenic yellow corn
supplement (Yellow extract) as control, alone or in combination
with acetyl salicylic acid (ASA) as reference drug. Results show a
significant amelioration of allodynia in rats drinking Red extract,
which is fully comparable to ASA-induced effect. The positive
effect on painful behavior is linked to both peripheral and central
actions and involves the normalization of glial cell activation.
MATERIALS AND METHODS
Animals
Male adult Sprague-Dawley rats (200–250 g; Charles River
Lab., Calco, Italy) were utilized, as previously described (Magni
et al., 2015). Animals were housed under standard conditions
(temperature 22 ± 2◦C; relative humidity 50 ± 10%; artificial
light 12 h light/dark cycle with lights on at 7 AM). Water
and food were provided ad libitum until the beginning
of corn supplement administration (see below). Experiments
were performed between 9:00 and 16:00 in the rat housing
room, whereas sacrifice took place in a separate operatory
room. The study was carried out in accordance with the
principles of the Basel Declaration and recommendations of the
Committee for Research and Ethical Issues of the International
Association for the Study of Pain (IASP), and with National
and European regulations regarding the protection of animals
used for experimental and other scientific purposes (D.L.
26_2014; 2010/63/UE), as well as following the Society for
Neuroscience’s policies on the Use of Animals and Humans
in Neuroscience Research. The study protocols have been
approved by the Council of the Department of Pharmacological
and Biomolecular Sciences and by the ethics committee
(OPBA) of the Università degli Studi di Milano (Milan, Italy).
Formal authorization (#736/2015-PR) was granted by the Italian
Ministry of Health, after positive evaluation by the Italian
Institute of Health, Rome. All efforts have been made to
minimize animal suffering, and to reduce the number of animals
to a minimum.
Preparation of Corn Supplements and
Their Administration to Animals
Red extract was produced by SVEBA Srl (Appiano Gentile, Italy)
from B1 Pl1 purple corn cobs through extraction with ethanol:
H2O (30:70 v/v) at 55◦C for 1 h, titrated to a concentration
of 4% ACNs and spray-dried to a final concentration of
31.25 mg/g of ACNs. Yellow extract was produced from b1 pl1
yellow corn cobs using identical protocols and volumes as
Red extract. A comparable total amount of flavonoids in
Red and Yellow extract, apart from ACNs, as in the original
raw plant material was previously verified (Petroni et al.,
2017).
The average volume of water drunk by each animal was
evaluated during a 3-day period. Identical quantities of Yellow
and Red extracts were then dissolved in water, so that a daily
amount of 53 mg of ACNs/kg body weight was administered to
animals. Control animals received water. Administration started
at Day-11 with respect to Complete Freund’s Adjuvant (CFA)
injection, i.e., when the training was started, and was continued
up to animals’ sacrifice (see Figure 1A).
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FIGURE 1 | Red extract is as effective as acetyl salicylic acid (ASA) in reverting trigeminal allodynia. (A) Schematic representation of the experimental protocol utilized
in this study. See “Materials and Methods” section for details. (B) Evaluation of facial allodynia in rats drinking water, Yellow or Red extracts and exposed to trigeminal
sensitization by Complete Freund’s Adjuvant (CFA) injection in the temporomandibular joint (TMJ). The head withdrawal threshold was evaluated at 24, 48 and 72 h
post CFA injection in the morning (see (A)), in 25 rats for the Water group and 33 rats each for the Yellow and Red groups. ###p < 0.001 with respect to
corresponding “PRE” values, one-way ANOVA followed by Tukey’s test; ∗∗p < 0.01 ∗∗∗p < 0.001 with respect to purple corn supplement, one-way ANOVA followed
by Bonferroni test. (C) Evaluation of facial allodynia in CFA-injected animals drinking water, Yellow or Red extracts and treated with ASA or saline. For each condition
(i.e., rats drinking water, yellow or purple corn supplements), light colored-bars represent the head withdrawal threshold evaluated at 48 h post CFA injection in the
morning, whereas the dark colored-bars represent the head withdrawal threshold evaluated in the afternoon, 30 min after i.p. saline or 50 mg/kg ASA. Similar results
have been obtained at 24 and 72 h post CFA injection (not shown). N = 8 (Water) and 9 (Yellow and Red) rats treated with saline, and 8 (Water) and 11 (Yellow and
Red) rats treated with ASA. ∗∗p < 0.01 with respect to Red extract, two-way ANOVA followed by Bonferroni test; #p < 0.05 with respect to corresponding value in
the morning, Students’ t-test.
Induction of TMJ Inflammation and
Administration of ASA
Rats were anesthetized with 1.5% isoflurane and unilateral
subchronic TMJ inflammation was induced by the injection
of 60 µl of CFA (Sigma-Aldrich, Milan, Italy) oil/saline
1:1 emulsion into the left TMJ capsule, as described (Villa
et al., 2010; Magni et al., 2015). The site of injection was
identified by palpating the zygomatic arch and condyle,
and the injection was delivered by advancing a 27-gauge
needle medioanteriorly through the skin immediately below
the posteroinferior border of the zygomatic arch until it
entered into the joint capsule. Injection was slowly performed
over 1 min. In selected experiments, some CFA-injected rats
drinking water or Yellow/Red extracts received 50 mg/kg
ASA in 2 ml saline solution i.p. at 24, 48 and 72 h
post CFA injection (in the afternoon; Magni et al., 2015).
Saline was administered as control to a different group of
CFA-injected rats drinking water or Yellow/Red extracts (see
Figure 1A).
Evaluation of Orofacial Allodynia by Von
Frey Behavioral Test
Orofacial mechanical allodynia was measured as described
(Villa et al., 2010; Magni et al., 2015). Briefly, a 1-week
training was performed before CFA injection to get the animals
acquainted with the operator and with the procedure. Diurnal
time variations were carefully avoided. Unrestrained rats were
probed with Von Frey filaments on the left and right orofacial
skin region, near to the center of the vibrissae pad. Filaments
were utilized in ascending series, with the starting filament
corresponding to Log unit 4.31 (force: 2g). Each filament was
tested five times at an interval of few seconds, and the response
threshold was defined as the lowest force eliciting at least three
head withdrawal responses out of five tests. The elapsed time
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between different filaments was 2 min. Thus, a specific pre-CFA
injection head withdrawal threshold value was calculated for
each animal. After CFA injection, evaluation of mechanical
allodynia was performed 24, 48 and 72 h later (in the morning;
Figure 1A). For sensitized inflamed animals, the force of the
starting filament was reduced to Log unit 3.22 (force 0.16 g). In
selected experiments, ASA or saline were administered 24, 48 and
72 h post CFA injection (in the afternoon; see above), and the
Von Frey test was repeated 30 min later (Figure 1A).
Immunohistochemistry
Rats were deeply anesthetized with ketamine (90mg/kg) and
xylazine (10mg/kg), and transcardially perfused with PBS
followed by 4% formalin, as previously described (Villa et al.,
2010). The left and right (ipsi- and contra-lateral to the side
of CFA injection, respectively) trigeminal ganglia (TG) and the
brainstem were excised, postfixed in 4% formalin for 60–90 min,
cryoprotected in 30% sucrose (48 h), embedded in mounting
medium (OCT; Tissue Tek, Sakura Finetek, Zoeterwoude,
Netherlands), and cut longitudinally on a cryostat at 15 µm
thickness. TGs from each animal were embedded together.
TG and brainstem (at the level of the medulla oblongata;
Villa et al., 2010) sections were then immunostained with a
rabbit primary antibody against the microglia marker ionized
calcium binding adaptor molecule 1 (anti-Iba1, 1:500; Wako,
Richmond, VA, USA) followed by a goat anti-rabbit secondary
antibody conjugated to AlexaFluorr488 (1:600; Thermo Fisher
Scientific, Monza, Italy). The specificity of the staining was
evaluated by incubating sections with secondary antibody only
(Supplementary Figure S1). Cell nuclei were counterstained
with the Hoechst33258 dye (1:20,000; Sigma-Aldrich, Milan,
Italy).
Image Analysis
Cell Counting
The number of Iba1+ cells was counted in whole TG or brainstem
slices acquired at 20×magnification and expressed as number of
cells/area in µm2. At least three samples from three animals were
evaluated.
Evaluation of Microglia Morphology and Branch
Complexity
Digital images of whole Iba1-immunostained brainstem sections
were acquired at 20× magnification and converted to binary
grayscale to better analyze microglial cells morphology. The
average cell size and the integrated optical density were evaluated
by the ‘‘Particle analysis’’ tool of the Fiji-ImageJ software
(Schindelin et al., 2012).
Primary Microglia Cultures and in vitro
Pharmacological Treatments With Corn
Extracts
Primary microglia cultures were prepared as described (Chen
et al., 2007). Briefly, mixed glia cultures were obtained from
P2 Sprague-Dawley rat cortex and plated in 75-cm2 flasks
in DMEM high glucose supplemented with 20% FBS. After
7 days in culture, microglia were detached from the underlying
cells by shaking the flasks for 20 min at 200 rpm and
plated into poly-D-lysine coated plates in DMEM high glucose
supplemented with 15% FBS. Cells were seeded at 0.7–1 × 106
cell/well in 12-well plates coated with poly-D-lysine (0.1 mg/ml)
and overnight treated with Yellow or Red extracts (at a
concentration corresponding to 125 µM ACNs, considering
cyanidin 3-glucoside (C3G) MW: 484.84 g/mol, as the most
abundant component) or medium alone, followed by a 6-h
challenge with 1 µg/ml LPS (or medium as control). At the
end of incubation, the medium was discarded, adherent cells
were rinsed twice with ice-cold PBS, and lysed with 300 µl/well
Qiazolr Lysis Reagent (Qiagen, Hilden, Germany) for RNA
extraction.
Real Time RT-PCR Assays
Total RNA was isolated from cells with Direct-ZolTM RNA
MiniPrep kit (Zymo Research, Irvine, CA, USA). About
1 µg RNA was reverse-transcribed with RT SuperscriptTM
II (Invitrogen, Carlsbad, CA, USA) and Real time RT-PCR
performed with Fast Evagreen qPCR Master Mix (Bio-Rad,
Segrate, Italy) in a CFX96 real-time PCR detection system (Bio-
Rad). The expression of each transcript was normalized against
GAPDH and values were expressed as Fold Change over control
sample (CNT). Primer sequences are reported in Table 1. Data
are presented as mean± SEM.
Western Blotting
Primary microglia were lysed in a buffer containing 50 mM
Tris–HCl, pH 7.2, 0.1% sodium deoxycholate, 1% Triton X-100,
5 mM EDTA, 5 mM EGTA, 150 mM NaCl, 40 mM NaF,
2.175 mM NaVO4, 0.1% SDS, 0.1% aprotinin and 1 mM
PMSF. Ten micrograms of protein underwent SDS–PAGE
following transfer on nitrocellulose membranes. Bands were
TABLE 1 | Primer sequences utilized for real time RT-PCR.
Gene Primer sequence 5′-3′
TNF-α-fw GCAGATGGGCTGTACCTTATC
TNF-α-rv GAAATGGCAAATCGGCTGAC
IL-6-fw GCCAGAGTCATTCAGAGCAATA
IL-6-rv TTAGGAGAGCATTGGAAGTTGG
IL-10-fw AGTGGAGCAGGTGAAGAATG
IL-10-rv GAGTGTCACGTAGGCTTCTATG
iNOS-fw GTGGCTGTGGTCACCTATC
iNOS-rv GTCTTCGGGCTTCAGGTTATT
MCP1-fw CTGGCAAGATGATCCCAATGA
MCP1-rv TCTCTTGAGCTTGGTGACAAATA
Arg1-fw ACAAGACAGGGCTACTTTCAGG
Arg1-rv ACAAGACAAGGTCAACGCCA
IL1β-fw TGGCAACTGTCCCTGAACTC
IL1β-rv GTCGAGATGCTGCTGTGAGA
YM-1-fw GACACAATCCAGTCTGGTTACA
YM-1-rv CAGTGTCGGATGGAGATTGATAG
Fizz1-fw GAAGACCCTCTCATGCACTAAT
Fizz1-rv ACAGGCAAAGCCACAAGA
IL-13-fw ACATCACACAAGACCAGAAGAC
IL-13-rv GGAGATGTTGGTCAGGGATTC
GAPDH-fw TGTGAACGGATTTGGCCGTA
GAPDH-rv ATGAAGGGGTCGTTGATGGC
fw, forward; rv, reverse.
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detected using PierceTM ECL Western Blotting Substrate
(ThermoFisher Scientific, Waltham, MA, USA) on a Chemidoc
digital imaging machine. We utilized an anti-iNOS rabbit
primary antibody (1:200 in 1% BSA; Cayman Chemical, Ann
Arbor, MI, USA) followed by a goat anti-rabbit horseradish
peroxidase-conjugated secondary antibody (1:3,000; Bio-Rad,
Hercules, CA, USA). Internal loading control was performed
by anti-α-Tubulin mouse primary antibody (1:500 in 1%
BSA; Sigma-Adrich, St. Louis, MO, USA) followed by a goat
anti-mouse horseradish peroxidase-conjugated secondary
antibody (1:1,000; Sigma-Aldrich, St. Louis, MO, USA;
see Supplementary Figure S2 for antibody specificity).
Densitometry quantification was performed with ImageJ
Software (NIH) and expressed as ratio of iNOS to α-tubulin.
Statistics
Groups were compared by one- or two-way ANOVA followed by
Bonferroni or Tukey post hoc tests for multiple comparisons or
by Student’s t-test, when appropriate, as reported in the Legends
to Figures using GraphPad Prism 6.0 software. p < 0.05 was
considered statistically significant.
RESULTS
Anti-allodynic Effect of Red Extract in a
Rat Model of Trigeminal Sensitization and
Comparison With Acetyl Salicylic Acid
(ASA)
We first evaluated the effect of a prolonged (i.e., up to 14 days)
consumption of purple corn supplement (Red extract) on facial
mechanical allodynia due to CFA-induced TMJ inflammation
(see Figure 1A for a schematic representation of the experimental
protocol). Starting 24 h post CFA injection, rats drinking water
showed a significant reduction in the head withdrawal threshold
at Von Frey test with respect to the mean value pre-CFA
injection (Figure 1B; from 30.81 ± 2.21 of ‘‘pre’’ value to
8.76 ± 0.62 at 24 h post CFA), which lasted until animals’
sacrifice (i.e., 8.56 ± 0.92 at 72 h post CFA-injection). Rats
drinking yellow corn supplement (Yellow extract) showed an
identical pattern of response, whereas after administration of
Red extract a significantly higher value of the head withdrawal
threshold (19.82 ± 2.07 at 24 h) was observed, and stably lasted
up to sacrifice, indicating a partial but significant prevention of
the development of mechanical allodynia by Red extract.
We next asked whether Red extract can synergize with
a known anti-inflammatory drug, i.e., ASA, that we already
demonstrated to exert significant anti-allodynic action on
CFA-injected animals (Magni et al., 2015). When comparing the
values of the head withdrawal threshold measured 48 h post
CFA injection (light-colored bars in Figure 1C) or 30 min after
ASA administration in the afternoon of the same day (dark-
colored bars in Figure 1C), a marked anti-allodynic action of
ASA was unveiled in theWater and Yellow groups, while a much
smaller improvement was observed in the Red group. This is a
consequence of the significant anti-allodynic effect exerted by
the Red extract alone (Figure 1C, light red bars), which rose
the head withdrawal threshold to a mean value comparable to
values observed after ASA administration in the other two groups
(Figure 1C, histograms on the right). Thus, we can conclude
that a prolonged ingestion of Red extract is highly effective in
preventing the development of allodynia in animals exposed to
inflammatory trigeminal sensitization.
Red Extract and ASA Are Equally Effective
in Reducing CFA-Induced Trigeminal
Infiltration of Macrophages
The contribution of inflammatory cells, which migrate from
the bloodstream and infiltrate the trigeminal ganglion, to
FIGURE 2 | Red extract is as effective as ASA in inhibiting the trigeminal infiltration of Iba1+ macrophages in CFA-injected rats. (A–F) Representative micrographs of
Iba1 staining (green) in the ipsilateral trigeminal ganglia (TG) of CFA-injected animals drinking water (A,D), Yellow (B,E) or Red (C,F) extracts, treated with saline
solution (A–C) or 50 mg/kg ASA (D–F). Nuclei have been counterstained with the Hoechst33258 dye. Scale bars: 50 µm. The specificity of the anti-Iba1 primary
antibody is shown in Supplementary Figure S1. (G) Evaluation of the number of Iba1+ cells/area in the ipsilateral TG of CFA-injected animals drinking water, Yellow
or Red extracts and treated with saline (light colored-bars) or 50 mg/kg ASA (dark colored-bars). Animals have been sacrificed at 72 h post CFA injection (see
protocol in Figure 1 and text for details). N = 4 (Water), 3 (Yellow) and 5 (Red) rats treated with saline, and three (Water, Yellow and Red) rats treated with ASA.
∗∗p < 0.01 and ∗∗∗p < 0.001 with respect to purple corn supplement, two-way ANOVA followed by Bonferroni test; #p < 0.05 with respect to corresponding Saline
values, Students’ t-test.
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FIGURE 3 | Red extract inhibits the activation of Iba1+ microglia in the brainstem of CFA-injected rats. No effects of ASA. (A) Representative pictures of Iba1+
microglia in the medulla oblongata of the brainstem of CFA-injected rats drinking water, yellow or purple corn extracts (from top to bottom). Scale bars: 50 µm.
Insets: magnification of representative microglia cells, showing thinner and feebly stained processes in rats drinking Red extracts with respect to rats drinking water
or Yellow extract. Cells have been highlighted by dashed lines to perform quantitative analysis (see “Materials and Methods” section for details). (B) Histograms
showing the average cell size (top) and the mean integrated optical density of Iba1 staining (bottom) in CFA-injected animals drinking water, Yellow or Red extracts
and treated with saline (light colored-bars) or 50 mg/kg ASA (dark colored-bars). Animals have been sacrificed at 72 h post CFA injection (see protocol in Figure 1
and text for details). N = 4 (Water), 3 (Yellow) and 5 (Red) rats treated with saline, and three (Water, Yellow and Red) rats treated with ASA. ∗p < 0.05, ∗∗p < 0.01 and
∗∗∗p < 0.001 with respect to corresponding purple corn supplement, two-way ANOVA followed by Bonferroni test.
the development of trigeminal-related painful conditions has
been clearly established (Villa et al., 2010; Franceschini et al.,
2013; Batbold et al., 2017; Wang et al., 2018). We therefore
evaluated the number of trigeminal macrophages, identified
by the expression of Iba1, under the various experimental
conditions 72 h after CFA injection. In parallel with the effect
on the development of mechanical allodynia (see Figure 1),
a significantly lower density of Iba1+ cells in the trigeminal
ganglion with respect to water and Yellow extract was observed
in animals drinking Red extract (see representative pictures
in Figures 2A–C and quantification of data in histograms in
Figure 2G). Additionally, administration of ASA to animals
receiving either Water or Yellow extract was as effective
as Red extract alone in reducing macrophage infiltration
(Figures 2D–F), but ASA showed no additional effect on
the Red extract group (dark columns in Figure 2G). These
data suggest that Red extract-induced prevention of orofacial
allodynia proceeds through a peripheral anti-inflammatory
effect, which resembles the well-known effect of a marketed
NSAID.
Exclusive Effect of Red Extract on
Microglia Activation in vivo and in vitro
At central level, the development of trigeminal pain is directly
linked to the activation of microglia in the medulla oblongata
in the brainstem and in the cervical spinal cord (Villa et al.,
2010; Wang et al., 2018), i.e., in CNS areas in connection with
the trigeminal nerve. We have therefore deemed interesting
to analyze the possible effect of Red extract on microglia cell
number and shape changes, a typical correlate of their transition
from a resting to a pro-inflammatory phenotype (Walker
et al., 2014; Crews and Vetreno, 2016). Immunohistochemical
analysis of Iba1 staining in the brainstem did not reveal
differences in the total number of positive cells among the
three experimental groups (number of Iba1+ cells/area in µm2:
0.179 ± 0.020, 0.173 ± 0.022 and 0.166 ± 0.028 in the
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FIGURE 4 | In vitro treatment of LPS-activated rodent microglia with Red extract reduces the production of pro-inflammatory mediators. Rodent microglia cells were
grown in culture, overnight exposed to medium alone, Yellow or Red extracts, and then challenged with medium alone or 1 µg/ml LPS for 6 h (see “Materials and
Methods” section for details). Cells were then collected and the expression of pro-inflammatory cytokine genes was evaluated by Real time RT-PCR (A). Each
transcript was normalized to corresponding control value (V, vehicle). Values shown are mean ± SEM from two independent experiments performed in triplicate.
(B) Evaluation of iNOS protein levels by Western blotting and relative quantification. Filter is from one representative experiment out of three (see Supplementary
Figure S2 for the specificity of antibodies). Densitometric analysis of bands have been performed with ImageJ and values normalized to α-tubulin. Histograms show
the mean ± SEM values from three independent experiments performed in triplicate. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 with respect to cultures exposed to
Red extract, one-way ANOVA followed by Bonferroni post hoc tests.
Water, Yellow and Red group, respectively; not statistically
significant, five slices from two animals/condition). Conversely,
striking differences in microglia cell morphology were observed
between the Red and the Water/Yellow groups, as shown
by insets in representative pictures in Figure 3A. Thicker
and highly stained cell processes, indicative of microglia
activation, were in fact detected in both the Water and Yellow
groups. Administration of Red extract significantly reduced
both cell size and Iba1 staining intensity (see quantification in
Figure 3B), with microglia morphology characterized by very
thin processes, typical of a resting phenotype (see Figure 3A,
inset). Concomitant administration of ASA did not modify
either parameter of microglia activation in any experimental
condition (Figure 3B). This suggests multiple mechanisms
of action for Red extract, targeting both infiltrating cells in
peripheral tissues (see above) and resident glia cells in the
CNS, whereas ASA exerts only a peripheral anti-inflammatory
action.
To verify whether Red extract can directly influence microglia
functions, we have pre-treated primary microglia cultures with
medium alone, Yellow or Red extracts and then simulated cell
activation by incubation with LPS. The expression of pro- or
anti-inflammatory mediators has been then evaluated by Real
Time RT-PCR. As shown in Figure 4A, pre-treatment of cultures
with Red extract completely reverted LPS-promoted expression
of pro-inflammatory IL-6, TNF-α, IL-1β, MCP-1 and iNOS.
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FIGURE 5 | In vitro treatment of LPS-activated rodent microglia with Red extract induces the expression of anti-inflammatory mediators. Rodent microglia cells were
grown in culture, overnight exposed to medium alone, Yellow or Red extracts, and then challenged with medium alone or 1 µg/ml LPS for 6 h (see “Materials and
Methods” section for details). Cells were then collected, and the expression of anti-inflammatory genes was evaluated by Real time RT-PCR. Each transcript was
normalized to corresponding control value (V, vehicle). Values shown are mean ± SEM from two independent experiments performed in triplicate. ∗∗∗p < 0.001 with
respect to cultures exposed to Red extract, one-way ANOVA followed by Bonferroni post hoc tests.
Additionally, we verified whether the reduced transcript level of
the iNOS gene correlated with a decrease in iNOS protein. The
expression of iNOS protein was up-regulated in LPS-induced
primary microglia cells, but significantly inhibited to the level
of the untreated control group when cells were pre-treated with
Red extracts (Figure 4B). At the same time, Red extract induced
a significant up-regulation of anti-inflammatory mediators,
such as Arg-1, IL-10, Fizz1 and IL-13 and of the marker of
anti-inflammatorymicroglia phenotype YM-1 (Figure 5). Yellow
extract was partially effective in reducing the expression of some
of the pro-inflammatory mediators and only upregulated YM-1
among anti-inflammatory genes (Figures 4A, 5). Taken together,
these data suggest a direct action of Red extract on microglia
function and activation.
DISCUSSION
Non-neuronal Cells as Targets for the
Management of Trigeminal Allodynia
The present work is the first demonstration of the anti-allodynic
effect of purple corn extract in a rat model of trigeminal
sensitization, which involves both peripheral infiltrating
macrophages and central glial cells. Targeting non-neuronal
cells, including macrophages and glial cells, has now emerged as
a promising and effective approach for many painful conditions,
including head and face pain and allodynia. For example, both
peripheral macrophages and central microglia are involved in
the development of chronic pain due to forced prolonged mouth
opening and TMJ inflammation, and inhibiting their activation
leads to significant amelioration of pain (Wang et al., 2018).
Additionally, macrophages infiltrating the trigeminal ganglion
are directly involved in the development of ectopic orofacial
pain following the transection of the inferior alveolar nerve, and
their depletion or the blockade of inflammatory pathways are
protective against allodynia (Batbold et al., 2017). We previously
demonstrated that macrophage trigeminal infiltration and
central microgliosis are hallmarks of inflammatory trigeminal
pain due to CFA injection in the TMJ (Villa et al., 2010), the
animal model utilized in the present study, suggesting that these
cell types significantly contribute to the development of pain.
The Anti-inflammatory Effects of
Anthocyanins Involve the Shift of Microglia
Towards a Neuroprotective Phenotype
The Janus face of microglia cells is demonstrated by their
ability to contribute and sustain inflammation or to promote
brain tissue repair and resolution of inflammatory processes,
thanks to the expression of either pro- or anti-inflammatory
mediators, respectively. This has led to the long-utilized
sub-classification of microglia cells as M1 (detrimental) or M2
(reparative) phenotypes (Kierdorf and Prinz, 2013; Orihuela
et al., 2016). Although this classification is currently debated
by several authors, as too simplistic to adequately mirror the
vast variety of intermediate activation states of these cells
(Ransohoff, 2016), it is still undoubted that microglia cells
can be activated and respond to changes in their extracellular
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milieu by playing either detrimental or beneficial roles. It has
been demonstrated that ACN treatment inhibits LPS-induced
microglial activation in vitro (Poulose et al., 2012; Jeong et al.,
2013). However, despite increasing fractalkine expression, single
purified ACNs (i.e., cyanidin, C3G, or methylated C3G) did
not significantly promote microglial polarization towards an
anti-inflammatory phenotype (Meireles et al., 2016). ACNs can
cross the blood-brain barrier in significant amounts following
systemic administration (Hribar and Ulrih, 2014), and therefore
a protective effect can be predicted also in vivo. A very recent
article demonstrated the beneficial effects of ACNs on the
CNS in a mouse model of LPS-induced neuroinflammation
and memory loss, with a significant reduction of microglia
activation after administration by oral gavage of ACNs purified
from bilberry (Carvalho et al., 2017). Our results confirm and
extend these published data, demonstrating that purple corn
extract inhibits microglia activation and promotes their shift
towards the production of anti-inflammatory mediators and
that more than one component within purple corn ACNs may
promote this shift. Furthermore, we have utilized a crude purple
corn extract which can be easily prepared at a lower cost than
purified ACNs. Based on the amount of Red supplement drunk
by animals, we calculated that about 53 mg ACNs/kg body
weight have been assumed daily by animals, in line with the
amount of ACNs administered by gavage in published studies
(Carvalho et al., 2017). Being animals free to drink the Red extract
dissolved in water, instead of being forcedly administered to oral
gavage, represents an important add-on of our protocol which
demonstrates animals’ compliance to the treatment and more
closely resembles a possible clinical administration.
Concerning the possible molecular mechanisms at the basis
of the anti-inflammatory effects of Red extract, our data show a
significant reduction of iNOS expression in vitro. This could be
related to the activation of PPAR-γ receptors which have already
been demonstrated to inhibit LPS-stimulated iNOS expression
and TNF-α production as well as IFN-γ-induced expression of
major histocompatibility complex class II antigens, by preventing
the activation of the transcription factors STAT-1 and NF-κB in
rodent microglia in vitro (Bernardo and Minghetti, 2006). ACNs
from purple corn have been recently demonstrated to activate
PPAR-γ receptors in adipocytes (Luna-Vital et al., 2017), thus
it will be worth evaluating whether this signaling pathway can
be activated in microglia cells as well. Additionally, it has been
shown that ACNs exert their anti-inflammatory properties by
inhibiting the LPS- or cytokine-induced nuclear translocation
of the transcription factor NF-kB in multiple cell types (Kim
et al., 2006; Limtrakul et al., 2015; Ferrari et al., 2016). Thus,
a possible inhibition of NF-kB-mediated signaling pathways
by purple corn ACNs can also be speculated in microglia
cells.
Other Possible Mechanisms Implicated in
the Anti-allodynic Action of Red Extract in
Trigeminal Pain
Besides its direct action onmicroglia cells, we cannot exclude that
other more indirect mechanisms are involved in the observed
effect of Red extract. Thanks to its oral prolonged administration,
we can foresee its possible influence on the composition of gut
microbiota. A wealth of studies has been recently published
demonstrating a close interconnection between commensal
bacteria in the intestine and brain development and functions
(reviewed in Sharon et al., 2016; Tognini, 2017; Gilbert
et al., 2018), so that alterations in microbiota composition
is now considered to be at the basis of many neurological
disorders. It is now emerging that ACNs are metabolized by
intestinal microbiota, and, on the other hand, they and/or
their metabolites can modulate the growth of specific bacterial
taxa (Faria et al., 2014). A direct effect of the so-called
gut-brain axis on microglia functions has been highlighted
(Chunchai et al., 2018), but no data are currently available to
correlate gut microbiota, microglial cells and the development
of orofacial pain. In future studies, we aim at verifying the
involvement of this important correlation in our experimental
model.
Future Clinical Exploitation of the
Anti-allodynic Effects of Red Extract as
Adjuvant in Pain Management
Whatever the molecular mechanism(s) involved, the peculiar
action of Red extract which exerts beneficial effects both in
the periphery and at the central level represents an innovative
preventive approach for the development of trigeminal-
related allodynia as a consequence of inflammatory pain. In
fact, inhibiting the recruitment to the pain pathways and
the activation of central glial cells could help controlling
and managing not only acute painful behaviors but, more
importantly, their transition to persistent chronic painful
conditions, which are triggered and sustained by glia-mediated
maladaptive plasticity of central brain circuits (Ji et al., 2013,
2016; Grace et al., 2014). Thus, the prolonged administration
of Red extract could prove beneficial in limiting pain responses
to acute conditions that will not eventually develop to chronic
situations. In fact, although a significant reduction of allodynia
can be observed in the presence of a peripheral site of action
only, as demonstrated by our data on the effect of ASA on
macrophages infiltrating the trigeminal ganglion, the additional
ability of purple corn to also prevent the activation of central
microglia represents a significant advantage.
Although significant concentrations of ASA have been
detected in the CNS after systemic administration (Ajmone-Cat
et al., 2010), we could not detect any influence on microglia
activation in our experimental model. The most plausible
hypothesis is that when administered after the induction
of trigeminal sensitization, as in our experimental protocol,
ASA cannot reach a sufficient brain concentration to revert
microglia activation but can only modulate and reduce the
peripheral events controlling orofacial allodynia. Due to its
significant gastric side effects and to its negative modulation
of blood clotting, a preventive and prolonged exposure to
analgesic concentrations of ASA, and NSAIDs in general, is
not recommended. On the other side, purple corn extract has
already proved its safety in humans in one currently ongoing
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clinical trial on breast cancer patients undergoing radiotherapy
(Cerletti et al., 2017). Thus, lacking any significant side effects,
purple corn extract represents an innovative option for the
prevention of orofacial pain following, for example, dental
surgery.
ACNs in purple corn mostly consist of C3G and its malonyl
derivatives, whereas peonidin 3-glucoside and pelargonidin
3-glucoside are present only in small amounts (Petroni et al.,
2014, 2017). Since all other phenolic acids and flavonoids are
identical between purple and yellow corn (Pilu et al., 2011),
the anti-allodynic effect of purple corn extract may be mainly
attributed to C3G and its derivatives. Nonetheless, animals drank
similar amounts of water and of the two corn extracts, thus
allowing us to exclude any influence of the quantity of swallowed
supplement on the observed behavioral effects.
The anti-inflammatory effects of ACNs from purple corn
have been previously demonstrated in several models of
systemic inflammation, in particular liver inflammation linked
to diabetes-like conditions (Li et al., 2012; Bhaswant et al., 2017).
ACNs from Korean black soybean have been proved efficacious
in reducing neuroinflammation in a rat model of Alzheimer’s
disease (González-Reyes et al., 2017). No data are currently
available on their role in inflammatory painful conditions, and
in modulating glial cell reactivity. Thus, our data support for the
first time the use of ACN-based supplements or functional foods
as adjuvant therapy for chronic pain conditions, targeting glial
cells (Möller and Boddeke, 2016).
Taken together, our results demonstrate a significant
prevention of the development of orofacial allodynia induced
by trigeminal inflammation by purple corn extract and suggest
that it represents a promising supplement for the control of
trigeminal pain, accompanied by a cost-efficient production and
no side effects.
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